| 17.59 -0.87 (-4.71%) | 08-14 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 22.47 | 1-year : | 26.24 |
| Resists | First : | 19.23 | Second : | 22.47 |
| Pivot price | 16.77  |
|||
| Supports | First : | 16.37 | Second : | 14.6 |
| MAs | MA(5) : | 18.42  |
MA(20) : | 16.34 |
| MA(100) : | 14.2 |
MA(250) : | 16.03 |
|
| MACD | MACD : | 0.7 |
Signal : | 0.5 |
| %K %D | K(14,3) : | 77.8 |
D(3) : | 84.5 |
| RSI | RSI(14): 59.6 |
|||
| 52-week | High : | 23.02 | Low : | 10.94 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ SDGR ] has closed below upper band by 36.2%. Bollinger Bands are 131% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 18.47 - 18.6 | 18.6 - 18.7 |
| Low: | 17.25 - 17.42 | 17.42 - 17.55 |
| Close: | 17.36 - 17.58 | 17.58 - 17.76 |
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Fri, 14 Aug 2026
Schrodinger Inc (SDGR) Stock Down 4.8% -- Now Undervalued? GF Sc - GuruFocus
Fri, 14 Aug 2026
Two New Schrödinger Hires Get Stock Awards Vesting Over Four Years - Stock Titan
Fri, 14 Aug 2026
Schrodinger, Inc. Stock 12‑Month Price Target Raised to $21.83, Implies 18% Upside - TradingView
Wed, 12 Aug 2026
Quantinno Capital Management LP Buys Shares of 174,095 Schrodinger, Inc. $SDGR - MarketBeat
Wed, 12 Aug 2026
Schrödinger (SDGR) Is Up 19.2% After AI Pact With BMS And Q2 Profitability - Has The Bull Case Changed? - simplywall.st
Mon, 10 Aug 2026
Dimensional Fund Advisors LP Cuts Holdings in Schrodinger, Inc. $SDGR - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Technology
|
|
|
Industry:
Software - Application
|
|
| Shares Out | 66 (M) |
| Shares Float | 58 (M) |
| Held by Insiders | 3 (%) |
| Held by Institutions | 95.7 (%) |
| Shares Short | 10,580 (K) |
| Shares Short P.Month | 10,020 (K) |
| EPS | -0.74 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 4.21 |
| Profit Margin | -21 % |
| Operating Margin | -70.6 % |
| Return on Assets (ttm) | -14.5 % |
| Return on Equity (ttm) | -16.2 % |
| Qtrly Rev. Growth | 7.5 % |
| Gross Profit (p.s.) | 2.24 |
| Sales Per Share | 3.94 |
| EBITDA (p.s.) | -2.25 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -127 (M) |
| Levered Free Cash Flow | -29 (M) |
| PE Ratio | -24.1 |
| PEG Ratio | 0 |
| Price to Book value | 4.17 |
| Price to Sales | 4.45 |
| Price to Cash Flow | -9.11 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|